Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stool DNA Test of Methylated Syndecan-2 for the Early Detection of Colorectal Neoplasia

15 Jun 2017

Abstract excerpt

Abstract Background: Although the incidence of colorectal cancer is steadily increasing, screening for colorectal cancer with conventional approaches is not routinely performed in China. Noninvasive screening methods are attractive options to resolve this issue. Syndecan-2 (SDC2) is frequently methylated in colorectal cancer. However, the value of a stool test of methylated SDC2 for the detection of colorectal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic factors in colorectal cancer
Share to Colorectal Cancer Screening and Detection
Share to Gastric Cancer Management and Outcomes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28619831
DOI: 10.1158/1055-9965.epi-17-0153

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stool DNA Test of Methylated Syndecan-2 for the Early Detection of Colorectal NeoplasiaPMID 28619831Read ↗

A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNASemantic proximity Read ↗

Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancerSemantic proximity Read ↗

Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNASemantic proximity Read ↗

A Stool DNA-Based SDC2 Methylation Test for the Early Detection of Colorectal Cancer in an Asymptomatic, High-Risk Population: A Multicenter Prospective Randomized TrialSemantic proximity Read ↗

Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancerSemantic proximity Read ↗

Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early DetectionSemantic proximity Read ↗

SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal CancerSemantic proximity Read ↗

Evaluating the Clinical Performance of SDC2/NDRG4 Methylation for Colorectal Cancer DetectionSemantic proximity Read ↗

Evaluating the Clinical Performance of a Dual-Target Stool DNA Test for Colorectal Cancer DetectionSemantic proximity Read ↗

Methylation of SDC2/TFPI2 and Its Diagnostic Value in Colorectal Tumorous LesionsSemantic proximity Read ↗

Plausibility of an extensive use of stool DNA test for screening advanced colorectal neoplasia.Semantic proximity Read ↗

DNA methylation biomarkers in stool for early screening of colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.